HUADONG MEDICINE(000963.SZ)

Last Updated 00:00:00
longbridge loading
Company Encyclopedia
View More
name
HUADONG MEDICINE
000963.SZ
Huadong Medicine Co., Ltd, together with its subsidiaries, engages in the wholesale and retail of pharmaceutical products in China and internationally. The company operates through Pharmaceutical Manufacturing, Pharmaceutical Distribution, Medical Aesthetics, and Industrial Microbiology segments. It offers Chinese medicine, immunosuppressive agents, endocrine, digestive system, antineoplastic, cardiovascular, antibiotic drugs, medical beauty field, and medical devices, as well as engages in pharmaceutical logistics and industrial microbiology activities. In addition, the company provides formulation filling, technical, transportation and warehousing services.
346.12 B
000963.SZMarket value -Rank by Market Cap -/-

Financial Score

19/05/2026 Update
B
Health Care DistributorsIndustry
Industry Ranking1/23
Industry medianC
Industry averageC
Score Analysis
Peer Comparison
  • Criteria
    Rating
  • Profit ScoreB
    • ROE14.07%B
    • Profit Margin7.95%B
    • Gross Margin33.94%C
  • Growth ScoreC
    • Revenue YoY4.33%C
    • Net Profit YoY-1.76%C
    • Total Assets YoY1.17%C
    • Net Assets YoY6.21%B
  • Cash ScoreC
    • Cash Flow Margin120.68%B
    • OCF YoY4.33%C
  • Operating ScoreA
    • Turnover1.11A
  • Debt ScoreB
    • Gearing Ratio34.63%B

Valuation analysis

portai
P/E
1Y
3Y
5Y
10Y
P/E
-
Industry Ranking
-/-
  • P/E
  • Price
  • High
  • Median
  • Low
P/B
1Y
3Y
5Y
10Y
P/B
-
Industry Ranking
-/-
  • P/B
  • Price
  • High
  • Median
  • Low
P/S
1Y
3Y
5Y
10Y
P/S
-
Industry Ranking
-/-
  • P/S
  • Price
  • High
  • Median
  • Low
Dividend Yield
1Y
3Y
5Y
10Y
Dividend Yield
-
Industry Ranking
-/-
  • Dividend Yield
  • Price
  • High
  • Median
  • Low

Institutional View & Shareholder

Analyst Ratings

Rating
Percentage
    • Price
      --
    • Highest
      --
    • Lowest
      --
    News
    View More

    Assessing Grand Pharmaceutical Group (SEHK:512) Valuation After China Drug Approvals And Earnings Update

    Simplywall·
    HK
    00512
    -1.56%
    SH
    513700
    0.00%
    SZ
    159992
    +0.13%
    Simplywall·
    HK
    00512
    -1.56%
    SH
    513700
    0.00%
    SZ
    159992
    +0.13%

    01:48 ETBelief BioMed and Grand Life Sciences Announced Exclusive Commercial Partnership in the Field of Hemophilia A, Bringing Innovative Gene Therapy to Chinese Patients

    prnewswire·
    SH
    CS精准医
    +0.18%
    SZ
    000963
    +0.07%
    HK
    00512
    -1.56%
    prnewswire·
    SH
    CS精准医
    +0.18%
    SZ
    000963
    +0.07%
    HK
    00512
    -1.56%

    Grand Pharmaceutical Wins China’s First Approval for Demodex Blepharitis Drug, Bolstering Ophthalmic Push

    Tip Ranks·
    SZ
    159929
    +0.24%
    SH
    588130
    +0.68%
    SZ
    000963
    +0.07%
    Tip Ranks·
    SZ
    159929
    +0.24%
    SH
    588130
    +0.68%
    SZ
    000963
    +0.07%

    East China Pharmaceutical Subsidiary Receives FDA Approval for Clinical Trial

    CoinLive·
    SZ
    000963
    +0.07%
    CoinLive·
    SZ
    000963
    +0.07%

    National Healthcare Security Administration: Key drug "Deferasirox" for treating "thalassemia" included in medical insurance

    36Kr·
    SZ
    002038
    +0.48%
    SH
    512290
    +0.21%
    SZ
    000963
    +0.07%
    36Kr·
    SZ
    002038
    +0.48%
    SH
    512290
    +0.21%
    SZ
    000963
    +0.07%
    © 2026 Longbridge｜Disclaimer